+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Myocardial Infarction Treatment Market Analysis & Trends - Industry Forecast to 2027

  • ID: 4699605
  • Report
  • Region: Global
  • 197 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Anthera Pharmaceuticals
  • Astrazeneca
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • Janssen Biotech, Inc.
  • Merck & Co. Inc.
  • MORE
The Global Myocardial Infarction Treatment Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include increasing incidence of cardiovascular diseases, huge growth chronic diseases such as diabetes, hypertension and chronic kidney diseases, recent technological developments in myocardial infarction treatment, and growth opportunities/investment opportunities.

By Product Type, market is categorized into antithrombotic agents, antiplatelet agents, beta-adrenergic blockers, angiotensin-converting enzyme (ace) inhibitors, vasodilators, analgesics, thrombolytics & anti-thrombotic agents, angiotensin-receptor blockers, glycoprotein iib/iiia inhibitors and plaque modification device.

Antithrombotic agents are further divided into heparin, bivalirudin and enoxaparin. Antiplatelet agents are subdivided into clopidogrel, aspirin and vorapaxar. Beta-adrenergic blockers are further divided into esmolol and metoprolol.

Angiotensin-converting enzyme (ace) inhibitors are subdivided into lisinopril, captopril and enalapril. Vasodilators are further divided into nitroglycerin. Analgesics are subdivided into morphine sulfate. Thrombolytics and anti-thrombotic agents are further divided into alteplase (t-pa) and tenecteplase.

Angiotensin-receptor blockers are subdivided into valsartan and candesartan. Glycoprotein iib/iiia inhibitors are further divided into tirofiban, abciximab and eptifibatide. Depending on distribution channel, market is classified into drug stores, hospital pharmacies and online drug stores, hospitals and clinic.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
Middle East
  • Saudi Arabia
  • UAE
  • Rest of Middle East
Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
Rest of the World
  • South Africa
  • Others
Report Highlights:
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anthera Pharmaceuticals
  • Astrazeneca
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • Janssen Biotech, Inc.
  • Merck & Co. Inc.
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing Incidence of Cardiovascular Diseases
3.1.2 Huge Growth Chronic Diseases such as Diabetes, Hypertension and Chronic Kidney Diseases
3.1.3 Recent Technological Developments in Myocardial Infarction Treatment
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Myocardial Infarction Treatment Market, By Product Type
4.1 Antithrombotic agents
DATA TABLE Antithrombotic agents Market Forecast to 2027 (US$ MN)
4.1.1 Heparin
DATA TABLE Heparin Market Forecast to 2027 (US$ MN)
4.1.2 Bivalirudin
DATA TABLE Bivalirudin Market Forecast to 2027 (US$ MN)
4.1.3 Enoxaparin
DATA TABLE Enoxaparin Market Forecast to 2027 (US$ MN)
4.2 Antiplatelet agents
DATA TABLE Antiplatelet agents Market Forecast to 2027 (US$ MN)
4.2.1 Clopidogrel
DATA TABLE Clopidogrel Market Forecast to 2027 (US$ MN)
4.2.2 Aspirin
DATA TABLE Aspirin Market Forecast to 2027 (US$ MN)
4.2.3 Vorapaxar
DATA TABLE Vorapaxar Market Forecast to 2027 (US$ MN)
4.3 Beta-adrenergic blockers
DATA TABLE Beta-adrenergic blockers Market Forecast to 2027 (US$ MN)
4.3.1 Esmolol
DATA TABLE Esmolol Market Forecast to 2027 (US$ MN)
4.3.2 Metoprolol
DATA TABLE Metoprolol Market Forecast to 2027 (US$ MN)
4.4 Angiotensin-Converting Enzyme (ACE) inhibitors
DATA TABLE Angiotensin-Converting Enzyme (ACE) inhibitors Market Forecast to 2027 (US$ MN)
4.4.1 Lisinopril
DATA TABLE Lisinopril Market Forecast to 2027 (US$ MN)
4.4.2 Captopril
DATA TABLE Captopril Market Forecast to 2027 (US$ MN)
4.4.3 Enalapril
DATA TABLE Enalapril Market Forecast to 2027 (US$ MN)
4.5 Vasodilators
DATA TABLE Vasodilators Market Forecast to 2027 (US$ MN)
4.5.1 Nitroglycerin
DATA TABLE Nitroglycerin Market Forecast to 2027 (US$ MN)
4.6 Analgesics
DATA TABLE Analgesics Market Forecast to 2027 (US$ MN)
4.6.1 Morphine sulfate
DATA TABLE Morphine sulfate Market Forecast to 2027 (US$ MN)
4.7 Thrombolytics and anti-thrombotic agents
DATA TABLE Thrombolytics and anti-thrombotic agents Market Forecast to 2027 (US$ MN)
4.7.1 Alteplase (t-PA)
DATA TABLE Alteplase (t-PA) Market Forecast to 2027 (US$ MN)
4.7.2 Tenecteplase
DATA TABLE Tenecteplase Market Forecast to 2027 (US$ MN)
4.8 Angiotensin-Receptor blockers
DATA TABLE Angiotensin-Receptor blockers Market Forecast to 2027 (US$ MN)
4.8.1 Valsartan
DATA TABLE Valsartan Market Forecast to 2027 (US$ MN)
4.8.2 Candesartan
DATA TABLE Candesartan Market Forecast to 2027 (US$ MN)
4.9 Glycoprotein IIb/IIIa inhibitors
DATA TABLE Glycoprotein IIb/IIIa inhibitors Market Forecast to 2027 (US$ MN)
4.9.1 Tirofiban
DATA TABLE Tirofiban Market Forecast to 2027 (US$ MN)
4.9.2 Abciximab
DATA TABLE Abciximab Market Forecast to 2027 (US$ MN)
4.9.3 Eptifibatide
DATA TABLE Eptifibatide Market Forecast to 2027 (US$ MN)
4.10 Plaque Modification Device
DATA TABLE Plaque Modification Device Market Forecast to 2027 (US$ MN)

5 Myocardial Infarction Treatment Market, By Distribution Channel
5.1 Drug Stores
DATA TABLE Drug Stores Market Forecast to 2027 (US$ MN)
5.2 Hospital Pharmacies
DATA TABLE Hospital Pharmacies Market Forecast to 2027 (US$ MN)
5.3 Online Drug Stores
DATA TABLE Online Drug Stores Market Forecast to 2027 (US$ MN)
5.4 Hospitals
DATA TABLE Hospitals Market Forecast to 2027 (US$ MN)
5.5 Clinic
DATA TABLE Clinic Market Forecast to 2027 (US$ MN)

6 Myocardial Infarction Treatment Market, By Geography
6.1 North America
DATA TABLE North America Market Forecast by Countries to 2027 (US$ MN)
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
DATA TABLE Europe Market Forecast by Countries to 2027 (US$ MN)
6.2.1 Germany
6.2.2 U.K
6.2.3 Italy
6.2.4 France
6.2.5 Spain
6.2.6 Rest of Europe
6.3 Asia Pacific
DATA TABLE Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
6.3.1 China
6.3.2 Japan
6.3.3 India
6.3.4 Australia
6.3.5 New Zealand
6.3.6 Rest of Asia Pacific
6.4 Middle East
DATA TABLE Middle East Market Forecast by Countries to 2027 (US$ MN)
6.4.1 Saudi Arabia
6.4.2 UAE
6.4.3 Rest of Middle East
6.5 Latin America
DATA TABLE Latin America Market Forecast by Countries to 2027 (US$ MN)
6.5.1 Argentina
6.5.2 Brazil
6.5.3 Rest of Latin America
6.6 Rest of the World (RoW)
DATA TABLE RoW Market Forecast by Countries to 2027 (US$ MN)
6.6.1 South Africa
6.6.2 Others

7 Key Player Activities
7.1 Acquisitions & Mergers
7.2 Agreements, Partnerships, Collaborations and Joint Ventures
7.3 Product Launch & Expansions
7.4 Other Activities

8 Leading Companies
8.1 Johnson & Johnson
8.2 Bayer
8.3 Daiichi Sankyo Company Limited
8.4 Janssen Biotech, Inc.
8.5 Boehringer Ingelheim GmbH
8.6 Pfizer Inc.
8.7 Sandoz
8.8 Sanofi
8.9 Eli Lilly and Company
8.10 Bristol-Myers Squibb Company
8.11 Apotex Inc
8.12 Par Pharmaceutical Companies, Inc
8.13 Mylan N.V
8.14 Portola Pharmaceuticals Inc.
8.15 GlaxoSmithKline Plc
8.16 Anthera Pharmaceuticals
8.17 Capricor Inc.
8.18 Novartis
8.19 Astrazeneca
8.20 Merck & Co. Inc.

List of Tables
Table 1 Global Myocardial Infarction Treatment Market, By Region Market Forecast (2015-2027) (US $MN)
Table 2 Global Myocardial Infarction Treatment Market, By Product Type Market Forecast (2015-2027) (US $MN)
Table 3 Global Myocardial Infarction Treatment Market, By Antithrombotic agents Market Forecast (2015-2027) (US $MN)
Table 4 Global Myocardial Infarction Treatment Market, By Heparin Market Forecast (2015-2027) (US $MN)
Table 5 Global Myocardial Infarction Treatment Market, By Bivalirudin Market Forecast (2015-2027) (US $MN)
Table 6 Global Myocardial Infarction Treatment Market, By Enoxaparin Market Forecast (2015-2027) (US $MN)
Table 7 Global Myocardial Infarction Treatment Market, By Antiplatelet agents Market Forecast (2015-2027) (US $MN)
Table 8 Global Myocardial Infarction Treatment Market, By Clopidogrel Market Forecast (2015-2027) (US $MN)
Table 9 Global Myocardial Infarction Treatment Market, By Aspirin Market Forecast (2015-2027) (US $MN)
Table 10 Global Myocardial Infarction Treatment Market, By Vorapaxar Market Forecast (2015-2027) (US $MN)
Table 11 Global Myocardial Infarction Treatment Market, By Beta-adrenergic blockers Market Forecast (2015-2027) (US $MN)
Table 12 Global Myocardial Infarction Treatment Market, By Esmolol Market Forecast (2015-2027) (US $MN)
Table 13 Global Myocardial Infarction Treatment Market, By Metoprolol Market Forecast (2015-2027) (US $MN)
Table 14 Global Myocardial Infarction Treatment Market, By Angiotensin-Converting Enzyme (ACE) inhibitors Market Forecast (2015-2027) (US $MN)
Table 15 Global Myocardial Infarction Treatment Market, By Lisinopril Market Forecast (2015-2027) (US $MN)
Table 16 Global Myocardial Infarction Treatment Market, By Captopril Market Forecast (2015-2027) (US $MN)
Table 17 Global Myocardial Infarction Treatment Market, By Enalapril Market Forecast (2015-2027) (US $MN)
Table 18 Global Myocardial Infarction Treatment Market, By Vasodilators Market Forecast (2015-2027) (US $MN)
Table 19 Global Myocardial Infarction Treatment Market, By Nitroglycerin Market Forecast (2015-2027) (US $MN)
Table 20 Global Myocardial Infarction Treatment Market, By Analgesics Market Forecast (2015-2027) (US $MN)
Table 21 Global Myocardial Infarction Treatment Market, By Morphine sulfate Market Forecast (2015-2027) (US $MN)
Table 22 Global Myocardial Infarction Treatment Market, By Thrombolytics and anti-thrombotic agents Market Forecast (2015-2027) (US $MN)
Table 23 Global Myocardial Infarction Treatment Market, By Alteplase (t-PA) Market Forecast (2015-2027) (US $MN)
Table 24 Global Myocardial Infarction Treatment Market, By Tenecteplase Market Forecast (2015-2027) (US $MN)
Table 25 Global Myocardial Infarction Treatment Market, By Angiotensin-Receptor blockers Market Forecast (2015-2027) (US $MN)
Table 26 Global Myocardial Infarction Treatment Market, By Valsartan Market Forecast (2015-2027) (US $MN)
Table 27 Global Myocardial Infarction Treatment Market, By Candesartan Market Forecast (2015-2027) (US $MN)
Table 28 Global Myocardial Infarction Treatment Market, By Glycoprotein IIb/IIIa inhibitors Market Forecast (2015-2027) (US $MN)
Table 29 Global Myocardial Infarction Treatment Market, By Tirofiban Market Forecast (2015-2027) (US $MN)
Table 30 Global Myocardial Infarction Treatment Market, By Abciximab Market Forecast (2015-2027) (US $MN)
Table 31 Global Myocardial Infarction Treatment Market, By Eptifibatide Market Forecast (2015-2027) (US $MN)
Table 32 Global Myocardial Infarction Treatment Market, By Plaque Modification Device Market Forecast (2015-2027) (US $MN)
Table 33 Global Myocardial Infarction Treatment Market, By Distribution Channel Market Forecast (2015-2027) (US $MN)
Table 34 Global Myocardial Infarction Treatment Market, By Drug Stores Market Forecast (2015-2027) (US $MN)
Table 35 Global Myocardial Infarction Treatment Market, By Hospital Pharmacies Market Forecast (2015-2027) (US $MN)
Table 36 Global Myocardial Infarction Treatment Market, By Online Drug Stores Market Forecast (2015-2027) (US $MN)
Table 37 Global Myocardial Infarction Treatment Market, By Hospitals Market Forecast (2015-2027) (US $MN)
Table 38 Global Myocardial Infarction Treatment Market, By Clinic Market Forecast (2015-2027) (US $MN)

Note: Tables for North America, Europe, APAC, Middle East, Latin America, and ROW Regions are also represented in the same manner as above.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Johnson & Johnson
  • Bayer
  • Daiichi Sankyo Company Limited
  • Janssen Biotech, Inc.
  • Boehringer Ingelheim GmbH
  • Pfizer Inc.
  • Sandoz
  • Sanofi
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Apotex Inc
  • Par Pharmaceutical Companies, Inc
  • Mylan N.V
  • Portola Pharmaceuticals Inc.
  • GlaxoSmithKline Plc
  • Anthera Pharmaceuticals
  • Capricor Inc.
  • Novartis
  • Astrazeneca
  • Merck & Co. Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4699605
Adroll
adroll